Contrary to startup culture, the best training for biotech leadership is gaining broad, cross-functional experience in a large, structured pharmaceutical company. This foundation provides the necessary depth and breadth to navigate the complexities of leading a smaller, resource-constrained biotech later on.

Jack Elands argues his background in commercial business development and sales was crucial for his success as a CEO. This experience taught him how to manage fundraising and investor communications—skills often underdeveloped in leaders with purely scientific backgrounds.

Kevin Pojasek credits his effectiveness to a deliberate 12-year journey through diverse roles—investing, company creation, research, and clinical operations. This broad experience allows a leader to understand how all parts of the company, from high-level strategy to detailed science, fit together.

A former medic explains that hands-on patient care provides an irreplaceable perspective for executives. It grounds strategic decisions in the reality of the patient experience, which is crucial for communicating value to teams and investors and maintaining a patient-first culture.

Derek Adams began in late-stage vaccine manufacturing at Merck before moving to earlier-stage companies. This "reverse" path provides a deep understanding of commercial realities, operational execution, and scale-up challenges that is invaluable for building a capital-efficient startup from the ground up.

Ron Cooper credits his success not to being a "scaling guy" at Bristol-Myers Squibb, but the "fix-it guy." Being deployed to turn around struggling business units across different geographies and therapeutic areas provided the multicultural, problem-solving toolkit essential for navigating the constant challenges of leading a biotech startup.

Jodie Morrison's path to CEO started from the bottom without a PhD or MD. This experience gave her a unique appreciation for all roles and levels, fostering an inclusive culture and a practical, operations-focused leadership style.

Despite experiences in biotech consulting and venture capital, CEO Andrew Obenshain cites his time as a primary care sales rep for Merck as his most formative job. This ground-level role provided an unparalleled understanding of the sales, marketing, and operational realities of the pharmaceutical industry, setting the foundation for his executive career.

Biotech CEOs with business-only backgrounds often possess a crucial humility about their scientific limitations. This forces them to prioritize hiring exceptional R&D talent and empowering them to succeed, avoiding the trap of micromanagement.